Researchers have been excited about the medication , a novel dual compound showing remarkable results in clinical trials for body loss . It works by targeting both systems: GLP-1 and GIP, which , when activated , support influence cravings and improve calorie burn. Early observations demonstrate noteworthy body reduction and likely advantages for p